Company News
AgelessRx Named to Inc.’s 2026 Best Workplaces List
For the second year running, AgelessRx has been named to Inc.'s Best Workplaces List, recognized for the culture, care, and people behind our mission to…
2025 Wrapped
2025 longevity trends highlight what changed this year, what actually matters, and how to build a smarter, more personalized longevity plan for 2026.
AgelessRx Named One of America’s Fastest-Growing Private Companies by Inc. Magazine
The mission-driven leader in longevity and telehealth earns national recognition on the 2025 Inc. 5000 list for its rapid revenue and membership growth. Ann Arbor,…
AgelessRx Named to Inc. Magazine’s 2025 Best Workplaces List
AgelessRx has been named by Inc. Magazine as one of the 2025 best workplaces! Discover what sets our culture apart.
AgelessRx Named Semi-Finalist in $101M XPRIZE Healthspan Global Competition
AgelessRx is a Semi-Finalist in the landmark XPRIZE Healthspan competition, a milestone that may propel longevity solutions to the spotlight.
AgelessRx Launches Methylene Blue, Pioneering Accessible Cognitive Longevity Solutions
New precision-dose solution offers a modern take on a time-tested compound, meeting the rising demand of proactive brain health.
AgelessRx Certified as an Official Vitalist Organization!
AgelessRx is now a Certified Vitalist Organization, advancing the longevity movement and fighting aging globally. Learn more about the certification and what it means for…
Introducing Infinite: Premium Longevity Support
Learn all about our latest doctor-formulated, daily longevity supplement.
AgelessRx Donates to Support Biology of Aging Research
Learn about AgelessRx's gift to the Michigan Medicine Division of Geriatric and Palliative Medicine Geriatrics Center.
PEARL Webinar Series: A Must-Watch Outlining Our Clinical Study
Check out this video webinar series about a new AgelessRx sponsored study on the use of Rapamycin in longevity treatment.
A Quick Update on PEARL, AgelessRx’s Upcoming Clinical Trial
AgelessRx has started recruiting participants to our clinical trial PEARL (Participatory Evaluation of Aging with Rapamycin for Longevity).
AgelessRx Launches Pilot Post-COVID Clinical Trial
Former ARX CMO Dr. Zalzala introduces new post-COVID-19 pilot study and shares how LDN and NAD+ may help with post-COVID-19 Syndrome.